Skip to main content
. 2019 Jan 22;16(2):233–248. doi: 10.1080/15476286.2019.1565665

Figure 1.

Figure 1.

FADD loss is associated with high expressions of miR-633 in gastric carcinoma.

(a) The predicted binding sequences for the miR-633 within the human FADD 3ʹ-UTR. b and c, FADD protein expression levels in gastric carcinoma tissues (b) and gastric cell lines (c), c = cancer tissues; n = matched adjacent tissues. (d) Immunohistochemistry staining of FADD in paraffin sections of patient tissues, scale bar = 50 μm. (e) normalized miR-633 expression levels in normal and cancer tissues from 26 pairs of gastric cancer patients. (f) qRT-PCR data of miR-633 expression in the gastric cell lines. (g) the correlation of miR-633 level and FADD protein level. Error bars represent S.D. Data are expressed as the mean ± SD of 3 independent experiments. *P < 0.05